19.665  0.535 (2.8%)		04-14 10:01
Open: 19.42 High: 19.98 Volume: 143,014		Pre. Close: 19.13 Low: 19.32 Market Cap: 5,557(M)

Short term
Mid term
Targets	6-month :	23.44	1-year :	27.37
Resists	First :	20.06	Second :	23.44
Pivot price	18.64
Supports	First :	17.72	Second :	16.28
MAs	MA(5) :	19.12	MA(20) :	18.65
	MA(100) :	23.07	MA(250) :	0
MACD	MACD :	-0.2	Signal :	-0.4
%K %D	K(14,3) :	70.9	D(3) :	68.9
RSI	RSI(14): 54
52-week	High :	42.5	Low :	16.28

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CAI ] has closed below upper band by 17.8%. Bollinger Bands are 23.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	19.47 - 19.58	19.58 - 19.68
Low:	17.58 - 17.71	17.71 - 17.84
Close:	18.92 - 19.13	19.13 - 19.32

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Mon, 13 Apr 2026
CAI Options Volatility — NASDAQ:CAI - TradingView — Track All Markets

Mon, 13 Apr 2026
CAI Options Chain — NASDAQ:CAI - TradingView — Track All Markets

Mon, 13 Apr 2026
Caris Life Sciences (NASDAQ:CAI) Shares Up 7.5% - Here's What Happened - MarketBeat

Mon, 13 Apr 2026
CAI Initiated by Jefferies -- Price Target Set at $28.00 - GuruFocus

Mon, 13 Apr 2026
Caris Life Sciences: Post-IPO Pullback Creates A Long-Term Buy Opportunity (NASDAQ:CAI) - Seeking Alpha

Mon, 13 Apr 2026
Jefferies Initiates Caris Life Sciences(CAI.US) With Buy Rating, Announces Target Price $28 - Moomoo

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	283 (M)
Shares Float	123 (M)
Held by Insiders	48.5 (%)
Held by Institutions	52.1 (%)
Shares Short	7,550 (K)
Shares Short P.Month	6,080 (K)

EPS	-3.23
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.03
Profit Margin	-8.4 %
Operating Margin	30.1 %
Return on Assets (ttm)	3.8 %
Return on Equity (ttm)	-45.4 %
Qtrly Rev. Growth	125.4 %
Gross Profit (p.s.)	1.91
Sales Per Share	2.87
EBITDA (p.s.)	0.23
Qtrly Earnings Growth	0 %
Operating Cash Flow	83 (M)
Levered Free Cash Flow	54 (M)

PE Ratio	-6.13
PEG Ratio	0
Price to Book value	9.67
Price to Sales	6.86
Price to Cash Flow	67.04

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.